Molecular Tumor Age Predicts Early DLBCL Progression

Company Ruijin Hospital (Shanghai Jiao Tong University School of Medicine) Event Type Preclinical/Translational Research Findings Modality Transcriptomic biomarker (molecular-age score) Asset Molecular-age risk score (research-stage biomarker, not a named clinical asset) Target Age-associated, progression-linked transcriptional programs Disease Area Diffuse large B-cell lymphoma (DLBCL), early progression…